Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

In the Novel Agents Era, Is the International Staging System Still Has the Prognostic Value in Patients with Renal Impairment?

Sung-Hoon Jung, MD PhD, Hee Kyung Kim, Seok Jin Kim, MD PhD, Seung-Shin Lee, MD, Jae-Sook Ahn, MDPhD, Yeo-Kyeoung Kim, MD PhD, Deok-Hwan Yang, MD PhD, Hyeoung-Joon Kim, MD PhD, Je-Jung Lee, Kihyun Kim

Blood (2015) 126 (23): 5313.

https://doi.org/10.1182/blood.V126.23.5313.5313

Published: 2015

Journal Articles

Whole Exome Sequencing Reveals That DNMT3A and ASXL1 Mutation Are Involved in the Development of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Patients without ABL1 Tyrosine Kinase Domain Mutation

Taehyung Simon Kim, Zhaolei Zhang, PhD, Marc Tyndel, Jae-Sook Ahn, MDPhD, Seunghyun Choi, PhD, Hyeoung Joon Kim, Jeffrey H. Lipton, MD PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 1568.

https://doi.org/10.1182/blood.V126.23.1568.1568

Published: 2015

Journal Articles

Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression

Taehyung Simon Kim, PhD, Zhaolei Zhang, PhD, Marc Tyndel, Jae-Sook Ahn, MDPhD, Yeo-Kyeoung Kim, MD, PhD, Seung Hyun Choi, PhD, Hyeoung-Joon Kim, MD PhD, Moses Lee, Murim Choi, Jeffrey H. Lipton, MD PhD, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 2596.

https://doi.org/10.1182/blood.V126.23.2596.2596

Published: 2015

Journal Articles

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

Jae-Sook Ahn, MDPhD, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD, PhD, Seung-Shin Lee, MD, Sung-Hoon Jung, MD PhD, Deok-Hwan Yang, MD PhD, Je-Jung Lee, Park Hee Jeong, Seung Hyun Choi, PhD, Chul Won Jung, MD PhD, Jun-Ho Jang, MD PhD, Heeje Kim, MD PhD, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD PhD, Sung-Hyun Kim, Dennis Dong Hwan Kim, MD PhD

Blood (2015) 126 (23): 3832.

https://doi.org/10.1182/blood.V126.23.3832.3832

Published: 2015

Journal Articles

An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype

Jae-Sook Ahn, MDPhD, Hyeoung-Joon Kim, MD PhD, Yeo-Kyeoung Kim, MD, PhD, Il-Kwon Lee, PhD, Nan Young Kim, Mark D Minden, MDPhD, Chul Won Jung, MD PhD, Jun-Ho Jang, MD PhD, Hee-Je Kim, Joon Ho Moon, MD, PhD, Sang Kyun Sohn, MD PhD, Jong-Ho Won, Sung-Hyun Kim, MD PhD, Namshin Kim, PhD, Kenichi Yoshida, MD PhD, Seishi Ogawa, MD PhD, Dennis Dong Hwan Kim, MDPhD

Blood (2014) 124 (21): 1052.

https://doi.org/10.1182/blood.V124.21.1052.1052

Published: 2014

NARROW

In the Novel Agents Era, Is the International Staging System Still Has the Prognostic Value in Patients with Renal Impairment?

Whole Exome Sequencing Reveals That DNMT3A and ASXL1 Mutation Are Involved in the Development of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Patients without ABL1 Tyrosine Kinase Domain Mutation

Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype

Email alerts

ASH Publications

American Society of Hematology

In the Novel Agents Era, Is the International Staging System Still Has the Prognostic Value in Patients with Renal Impairment?

Whole Exome Sequencing Reveals That DNMT3A and ASXL1 Mutation Are Involved in the Development of Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia Patients without ABL1 Tyrosine Kinase Domain Mutation

Whole Exome Sequencing Reveals the Landscape of Clonal Evolution from MDS to AML Progression

5-Hydroxymethylcytosine Is Correlated with TET2 or IDH1/2 Mutations However, May Not be a Prognostic Value to Predict the Survivals in Normal Karyotype AML

An Adverse Prognostic Effect of Homozygous TET2 Mutational Status on the Relapse Risk of Acute Myeloid Leukemia Patients of Normal Karyotype

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only